168 related articles for article (PubMed ID: 32703755)
1. Acute Ulceronecrotic Gastritis With Cytomegalovirus Reactivation: Uncommon Toxicity of Immune Checkpoint Inhibitors in Microsatellite Instability-High Metastatic Colorectal Cancer.
Hulo P; Touchefeu Y; Cauchin E; Archambeaud I; Chapelle N; Bossard C; Bennouna J
Clin Colorectal Cancer; 2020 Dec; 19(4):e183-e188. PubMed ID: 32703755
[No Abstract] [Full Text] [Related]
2. Cytomegalovirus-associated acute gastric mucosal lesion in an immunocompetent host.
Himoto T; Goda F; Okuyama H; Kono T; Yamagami A; Inukai M; Masugata H; Kobayashi M; Inoue H; Kinekawa F; Masaki T; Haba R; Ohashi E; Mori T; Senda S
Intern Med; 2009; 48(17):1521-4. PubMed ID: 19721296
[TBL] [Abstract][Full Text] [Related]
3. Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis.
Ferrian S; Liu CC; McCaffrey EF; Kumar R; Nowicki TS; Dawson DW; Baranski A; Glaspy JA; Ribas A; Bendall SC; Angelo M
Cell Rep Med; 2021 Oct; 2(10):100419. PubMed ID: 34755133
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus gastritis as a rare adverse event during combined ipilimumab and nivolumab in a patient with melanoma.
Indini A; Gueli R; Cerati M; Rijavec E; Parravicini M; Casagrande S; Rovelli C; Grossi PA; Grossi F
Melanoma Res; 2024 Aug; 34(4):386-389. PubMed ID: 38768445
[TBL] [Abstract][Full Text] [Related]
5. [CMV-associated gastric ulcer in an immunocompetent male patient].
Kastenbauer U; Ließ H; Kremer M
Internist (Berl); 2016 Jul; 57(7):724-7. PubMed ID: 27080250
[TBL] [Abstract][Full Text] [Related]
6. Current status and perspectives of immune checkpoint inhibitors for colorectal cancer.
Hirano H; Takashima A; Hamaguchi T; Shida D; Kanemitsu Y;
Jpn J Clin Oncol; 2021 Jan; 51(1):10-19. PubMed ID: 33205813
[TBL] [Abstract][Full Text] [Related]
7. A Case of Severe Acute Gastritis as an Immune-Related Adverse Event After Nivolumab Treatment: Endoscopic and Pathological Findings in Nivolumab-Related Gastritis.
Ebisutani N; Tozawa K; Matsuda I; Nakamura K; Tamura A; Hara K; Kondo T; Terada T; Tomita T; Oshima T; Fukui H; Hirota S; Miwa H
Dig Dis Sci; 2021 Jul; 66(7):2461-2465. PubMed ID: 32780186
[No Abstract] [Full Text] [Related]
8. [Treatment Strategy with Immune Checkpoint Inhibitors and Genetic Testing for Colorectal Cancer with Microsatellite Instability-High].
Yamazaki K; Kawakami T; Shirasu H; Fushiki K; Murase M; Murakami H
Gan To Kagaku Ryoho; 2022 Jul; 49(7):761-767. PubMed ID: 35851347
[TBL] [Abstract][Full Text] [Related]
9. Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer.
Morse MA; Overman MJ; Hartman L; Khoukaz T; Brutcher E; Lenz HJ; Atasoy A; Shangguan T; Zhao H; El-Rayes B
Oncologist; 2019 Nov; 24(11):1453-1461. PubMed ID: 31147488
[TBL] [Abstract][Full Text] [Related]
10. Antitumor response to microscopic melanoma in the gastric mucosa mimicking ipilimumab-induced gastritis.
Bello E; Cohen JV; Mino-Kenudson M; Dougan M
J Immunother Cancer; 2019 Feb; 7(1):41. PubMed ID: 30744698
[TBL] [Abstract][Full Text] [Related]
11. [Morphometric assessment of chronic gastritis in peptic ulcer and stomach cancer].
Deĭneka SV; Kononenko IN
Vrach Delo; 1989 Jul; (7):29-32. PubMed ID: 2800492
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Outcomes of Gastritis Associated With Immune Checkpoint Inhibitors: Scoping Review.
Obeidat A; Silangcruz K; Kozai L; Wien E; Fujiwara Y; Nishimura Y
J Immunother; 2022 Oct; 45(8):363-369. PubMed ID: 35972801
[TBL] [Abstract][Full Text] [Related]
13. Clinical Development of Immunotherapy for Deficient Mismatch Repair Colorectal Cancer.
Thomas J; Leal A; Overman MJ
Clin Colorectal Cancer; 2020 Jun; 19(2):73-81. PubMed ID: 32173280
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis.
Franklin C; Rooms I; Fiedler M; Reis H; Milsch L; Herz S; Livingstone E; Zimmer L; Schmid KW; Dittmer U; Schadendorf D; Schilling B
Eur J Cancer; 2017 Nov; 86():248-256. PubMed ID: 29055840
[TBL] [Abstract][Full Text] [Related]
15. Severe steroid refractory gastritis induced by Nivolumab: A case report.
Vindum HH; Agnholt JS; Nielsen AWM; Nielsen MB; Schmidt H
World J Gastroenterol; 2020 Apr; 26(16):1971-1978. PubMed ID: 32390707
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infective gastritis in an immunocompetent host misdiagnosed as malignancy on upper gastrointestinal endoscopy: a case report and review of literature.
Xiong X; Liu F; Zhao W; Ji X; Chen W; Zou H; Li F
Hum Pathol; 2019 Oct; 92():107-112. PubMed ID: 30584892
[TBL] [Abstract][Full Text] [Related]
17. The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors.
Corti F; Lonardi S; Intini R; Salati M; Fenocchio E; Belli C; Borelli B; Brambilla M; Prete AA; Quarà V; Antista M; Fassan M; Morano F; Spallanzani A; Ambrosini M; Curigliano G; de Braud F; Zagonel V; Fucà G; Pietrantonio F
Eur J Cancer; 2021 Jun; 150():155-167. PubMed ID: 33901794
[TBL] [Abstract][Full Text] [Related]
18. An update on the use of immunotherapy in patients with colorectal cancer.
Nguyen M; Tipping Smith S; Lam M; Liow E; Davies A; Prenen H; Segelov E
Expert Rev Gastroenterol Hepatol; 2021 Mar; 15(3):291-304. PubMed ID: 33138649
[No Abstract] [Full Text] [Related]
19. Severe necrotizing myositis associated with long term anti-neoplastic efficacy following nivolumab plus ipilimumab combination therapy.
Tauber M; Cohen R; Laly P; Josselin L; André T; Mekinian A
Clin Rheumatol; 2019 Feb; 38(2):601-602. PubMed ID: 30456528
[TBL] [Abstract][Full Text] [Related]
20. The gastric mucosal barrier.
Stern AI
Med J Aust; 1985 Feb; 142 Spec No():S9-10. PubMed ID: 4094579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
